Tag Archives: ATRS

Top 10 Value Stocks For 2019

Union Pacific (NYSE:UNP)‘s stock had its “hold” rating restated by equities research analysts at Cowen in a research note issued on Tuesday. They currently have a $151.00 target price on the railroad operator’s stock. Cowen’s target price points to a potential downside of 7.25% from the stock’s previous close.

UNP has been the topic of several other reports. ValuEngine raised shares of Union Pacific from a “hold” rating to a “buy” rating in a report on Thursday, August 2nd. Deutsche Bank cut shares of Union Pacific from a “buy” rating to a “hold” rating and set a $162.00 price target on the stock. in a report on Tuesday, August 14th. Morgan Stanley increased their price target on shares of Union Pacific from $125.00 to $136.00 and gave the company an “equal weight” rating in a report on Friday, June 1st. Loop Capital increased their price target on shares of Union Pacific to $153.00 and gave the company a “hold” rating in a report on Friday, June 1st. Finally, Stifel Nicolaus set a $151.00 price target on shares of Union Pacific and gave the company a “hold” rating in a report on Thursday, May 24th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and thirteen have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $150.14.

Top 10 Value Stocks For 2019: Maiden Hldgs Ltd(MHLD)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Maiden Holdings, Ltd. (NASDAQ:MHLD) dropped 14.5% during mid-day trading on Monday . The company traded as low as $2.60 and last traded at $2.65. Approximately 2,396,727 shares changed hands during mid-day trading, an increase of 263% from the average daily volume of 660,901 shares. The stock had previously closed at $3.10.

  • [By Lisa Levin]

     

    Losers
    Netshoes (Cayman) Limited (NASDAQ: NETS) shares dipped 43.73 percent to close at $2.87 on Tuesday as the company posted downbeat Q1 results.
    Cesca Therapeutics Inc. (NASDAQ: KOOL) shares dropped 29.01 percent to close at $0.80 after reporting Q1 results.
    SenesTech, Inc. (NASDAQ: SNES) shares fell 22.2 percent to close at $0.340 after reporting Q1 miss.
    Vipshop Holdings Limited (NYSE: VIPS) fell 19.95 percent to close at $12.08 after the company reported weaker-than-expected earnings for its first quarter on Monday.
    Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 19.68 percent to close at $3.775 after reporting earnings were down year over year. First quarter earnings came in flat, down from 4 cents per share in the same quarter of last year. Sales came in at $3.01 million.
    Boxlight Corporation (NASDAQ: BOXL) dropped 18.47 percent to close at $9.62 on Tuesday after surging 77.44 percent on Monday.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) declined 16.21 percent to close at $2.43. ENDRA Life Sciences is expected to release quarterly earnings today.
    ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares fell 16.13 percent to close at $1.79.
    Switch Inc (NYSE: SWCH) shares dropped 14.93 percent to close at $13.16 following a first-quarter earnings miss.
    Restoration Robotics Inc (NASDAQ: HAIR) fell 14.42 percent to close at $3.68 after reporting a first-quarter earnings miss.
    iCAD, Inc. (NASDAQ: ICAD) declined 13.01 percent to close at $3.41 following Q1 results.
    Intersections Inc. (NASDAQ: INTX) fell 12.44 percent to close at $1.97.
    Histogenics Corporation (NASDAQ: HSGX) declined 12.24 percent to close at $2.15.
    AZZ Inc. (NYSE: AZZ) fell 12.1 percent to close at $39.60 following Q3 earnings.
    Hallador Energy Company (NASDAQ: HNRG) fell 11.1 percent to close at $6.49.
    Integrated Media Technology Limited (NASDAQ: IMTE) dropped 10.66 percent to close at $16.93 on Tuesday.
    Myomo, Inc. (NYSE: MYO) slipp

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Booking Holdings Inc. (NASDAQ: BKNG) is projected to post quarterly earnings at $10.67 per share on revenue of $2.87 billion.
    CenturyLink, Inc. (NYSE: CTL) is expected to post quarterly earnings at $0.19 per share on revenue of $6.00 billion.
    Albemarle Corporation (NYSE: ALB) is projected to post quarterly earnings at $1.21 per share on revenue of $803.36 million.
    Spectra Energy Partners, LP (NYSE: SEP) is estimated to post quarterly earnings at $0.81 per share on revenue of $751.57 million.
    IAC/InterActiveCorp (NASDAQ: IAC) is expected to post quarterly earnings at $0.8 per share on revenue of $923.80 million.
    Open Text Corporation (NASDAQ: OTEX) is projected to post quarterly earnings at $0.62 per share on revenue of $691.75 million.
    Tutor Perini Corporation (NYSE: TPC) is expected to post quarterly earnings at $0.29 per share on revenue of $1.09 billion.
    Twenty-First Century Fox, Inc. (NASDAQ: FOXA) is projected to post quarterly earnings at $0.54 per share on revenue of $7.41 billion.
    ICU Medical, Inc. (NASDAQ: ICUI) is estimated to post quarterly earnings at $1.84 per share on revenue of $346.28 million.
    TechnipFMC plc (NYSE: FTI) is expected to post quarterly earnings at $0.33 per share on revenue of $3.13 billion.
    Synaptics Incorporated (NASDAQ: SYNA) is projected to post quarterly earnings at $0.91 per share on revenue of $401.76 million.
    The Dun & Bradstreet Corporation (NYSE: DNB) is expected to post quarterly earnings at $1.07 per share on revenue of $386.91 million.
    Matrix Service Company (NASDAQ: MTRX) is estimated to post quarterly earnings at $0.07 per share on revenue of $285.16 million.
    Maiden Holdings, Ltd. (NASDAQ: MHLD) is projected to post quarterly earnings at $0.21 per share on revenue of $739.31 million.
    tronc, Inc. (NASDAQ: TRNC) is expected to post quarterly earnings at $0.65 per share on revenue of $428.25 million.
    Copa Holdings,

  • [By Max Byerly]

    Horace Mann Educators (NYSE: HMN) and Maiden (NASDAQ:MHLD) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings.

Top 10 Value Stocks For 2019: Shenandoah Telecommunications Co(SHEN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    WINTON GROUP Ltd purchased a new stake in Shenandoah Telecommunications (NASDAQ:SHEN) during the first quarter, Holdings Channel reports. The firm purchased 24,122 shares of the utilities provider’s stock, valued at approximately $868,000.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks For 2019: Penn Virginia Resource Partners LP(PVR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    PVR Partners, L.P. (PVR) is engaged in the gathering and processing of natural gas and the management of coal and natural resource properties in the United States. The Company operates in three business segments: Eastern Midstream, Midcontinent Midstream and Coal and Natural Resource Management. In March 2014, Regency Energy Partners LP announced that it has acquired acquires all of PVR Partners, L.P’s outstanding units.

Top 10 Value Stocks For 2019: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Antares Pharma (NASDAQ:ATRS) was upgraded by investment analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued to investors on Friday.

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

  • [By Max Byerly]

    Antares Pharma (NASDAQ:ATRS) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Friday.

  • [By Brian Orelli]

    Shares of Antares Pharma (NASDAQ:ATRS) were up 11.8% at 3:12 p.m. EDT on Monday after the company announced a deal with Pfizer (NYSE:PFE) to develop a combination drug-device rescue pen.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Antares Pharma (ATRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks For 2019: Sky-mobi Limited(MOBI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media coverage about Sky-mobi (NASDAQ:MOBI) has trended somewhat positive this week, according to Accern Sentiment. The research group ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Sky-mobi earned a news impact score of 0.06 on Accern’s scale. Accern also assigned news stories about the software maker an impact score of 45.6853785900783 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Ethan Ryder]

    Mobius (CURRENCY:MOBI) traded 1.2% lower against the dollar during the 1-day period ending at 14:00 PM E.T. on August 21st. In the last week, Mobius has traded down 1.1% against the dollar. One Mobius token can now be bought for about $0.0291 or 0.00000452 BTC on popular cryptocurrency exchanges including GOPAX, BitMart, Gate.io and Stellar Decentralized Exchange. Mobius has a total market capitalization of $11.23 million and approximately $78,528.00 worth of Mobius was traded on exchanges in the last 24 hours.

  • [By Logan Wallace]

    Mobius (CURRENCY:MOBI) traded 12.4% lower against the US dollar during the 24 hour period ending at 17:00 PM E.T. on September 25th. One Mobius token can now be bought for approximately $0.0265 or 0.00000414 BTC on major cryptocurrency exchanges including Gate.io, Kucoin, BitMart and GOPAX. Over the last week, Mobius has traded up 8.8% against the US dollar. Mobius has a market cap of $10.22 million and approximately $69,762.00 worth of Mobius was traded on exchanges in the last day.

  • [By Logan Wallace]

    Mobius (CURRENCY:MOBI) traded up 0.1% against the dollar during the 24 hour period ending at 18:00 PM ET on February 11th. In the last week, Mobius has traded 3.1% lower against the dollar. One Mobius token can now be bought for approximately $0.0095 or 0.00000260 BTC on exchanges including OTCBTC, Gate.io, Stellar Decentralized Exchange and BitMart. Mobius has a total market capitalization of $4.89 million and approximately $19,445.00 worth of Mobius was traded on exchanges in the last day.

  • [By Stephan Byrd]

    Mobius (CURRENCY:MOBI) traded 5.5% higher against the dollar during the 24-hour period ending at 16:00 PM E.T. on February 21st. Mobius has a market cap of $6.06 million and $37,433.00 worth of Mobius was traded on exchanges in the last 24 hours. One Mobius token can now be purchased for $0.0118 or 0.00000298 BTC on popular cryptocurrency exchanges including GOPAX, Gate.io, BitMart and Stellarport. Over the last seven days, Mobius has traded up 22.4% against the dollar.

Top 10 Value Stocks For 2019: Otonomy, Inc.(OTIC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Alkermes (NASDAQ: ALKS) and Otonomy (NASDAQ:OTIC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, risk, profitability and earnings.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Otonomy (OTIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Otonomy (OTIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Otonomy (NASDAQ:OTIC) issued its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.44) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.38) by ($0.06), Fidelity Earnings reports. The company had revenue of $0.12 million for the quarter, compared to the consensus estimate of $0.30 million. Otonomy had a negative net margin of 6,316.88% and a negative return on equity of 58.60%.

  • [By Logan Wallace]

    Otonomy Inc (NASDAQ:OTIC) has received a consensus rating of “Hold” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $9.58.

Top 10 Value Stocks For 2019: Piedmont Office Realty Trust, Inc.(PDM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Nomura Asset Management Co. Ltd. decreased its holdings in shares of Piedmont Office Realty Trust, Inc. (NYSE:PDM) by 5.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 78,700 shares of the real estate investment trust’s stock after selling 4,900 shares during the period. Nomura Asset Management Co. Ltd. owned about 0.06% of Piedmont Office Realty Trust worth $1,568,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Piedmont Office Realty Trust, Inc. (NYSE: PDM) is an owner, manager, developer, and operator of high-quality, Class A office properties in select sub-markets located primarily within eight major U.S. office markets. Its geographically-diversified, almost $5 billion portfolio is currently comprised of approximately 17 million square feet. The Company is a fully-integrated, self-managed real estate investment trust (REIT) with local management offices in each of its major markets and is investment-grade rated by Standard & Poor's (BBB) and Moody's (Baa2). For more information, see www.piedmontreit.com.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Piedmont Office Realty Trust (PDM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Piedmont Office Realty Trust (PDM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Paul Ausick]

    Piedmont Office Realty Trust Inc. (NYSE: PDM) dropped about 3.5% Tuesday to post a new 52-week low of $17.35. Shares closed at $17.98 on Monday and the stock’s 52-week high is $22.74. Volume was about 60% above the daily average of around 1.3 million shares. The company had no specific news.

  • [By Ethan Ryder]

    Sumitomo Mitsui Trust Holdings Inc. reduced its holdings in shares of Piedmont Office Realty Trust (NYSE:PDM) by 2.4% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 131,748 shares of the real estate investment trust’s stock after selling 3,194 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about 0.10% of Piedmont Office Realty Trust worth $2,317,000 at the end of the most recent quarter.

Top 10 Value Stocks For 2019: United Bankshares Inc.(UBSI)

Advisors’ Opinion:

  • [By ]

    In the Lightning Round, Cramer was bullish on Salesforce.com (CRM) , American Airlines (AAL) , Align Technology (ALGN) , Procter & Gamble (PG) , United Bankshares (UBSI) , Valeant Pharmaceuticals (VRX) and Dominion Energy (D) .

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on United Bankshares (UBSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    BidaskClub upgraded shares of United Bankshares (NASDAQ:UBSI) from a hold rating to a buy rating in a research report sent to investors on Saturday.

  • [By Shane Hupp]

    Shares of United Bankshares, Inc. (NASDAQ:UBSI) have been assigned an average recommendation of “Hold” from the seven brokerages that are currently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $39.33.

  • [By Ethan Ryder]

    United Bankshares, Inc. (NASDAQ:UBSI) – Analysts at Boenning Scattergood reduced their Q2 2019 earnings estimates for shares of United Bankshares in a research report issued to clients and investors on Wednesday, January 30th. Boenning Scattergood analyst M. Schultheis now anticipates that the financial services provider will post earnings of $0.63 per share for the quarter, down from their previous estimate of $0.64. Boenning Scattergood has a “Hold” rating on the stock. Boenning Scattergood also issued estimates for United Bankshares’ Q3 2019 earnings at $0.65 EPS, Q4 2019 earnings at $0.63 EPS, FY2019 earnings at $2.55 EPS and FY2020 earnings at $2.60 EPS.

Top 10 Value Stocks For 2019: Wipro Limited(WIT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Millennium Management LLC decreased its holdings in Wipro Limited (NYSE:WIT) by 87.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,188 shares of the information technology services provider’s stock after selling 373,205 shares during the quarter. Millennium Management LLC’s holdings in Wipro were worth $280,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Wipro Limited (NYSE:WIT) – Equities research analysts at Jefferies Financial Group issued their FY2019 earnings per share estimates for Wipro in a research report issued to clients and investors on Tuesday, June 19th. Jefferies Financial Group analyst A. Sen expects that the information technology services provider will post earnings of $0.29 per share for the year. Jefferies Financial Group currently has a “Underperform” rating on the stock. Jefferies Financial Group also issued estimates for Wipro’s FY2020 earnings at $0.30 EPS.

  • [By Shane Hupp]

    Wipro Limited (NYSE:WIT) – Research analysts at Jefferies Financial Group issued their FY2021 earnings per share estimates for shares of Wipro in a research note issued to investors on Tuesday, June 19th. Jefferies Financial Group analyst A. Sen forecasts that the information technology services provider will post earnings of $0.31 per share for the year. Jefferies Financial Group currently has a “Underperform” rating on the stock.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Shane Hupp]

    Wipro Limited (NYSE:WIT) has been given an average rating of “Hold” by the eleven brokerages that are covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating on the company.

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to

Top 10 Value Stocks For 2019: International Speedway Corporation(ISCA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on International Speedway Corp Class A (ISCA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Garrett Baldwin]

    Money Morning Special Situations Strategist Tim Melvin unveiled his powerful secret to becoming the only undefeated trader that we know of on Wall Street. He has 119 stock-picking wins… and zero… that’s right, ZERO… losses. And he’s unveiled his strategy to an exclusive group of Money Morning readers. Find out how you too can become undefeated… right here.

    Stocks to Watch Today: STZ, AMZN, BKS
    Constellation Brands Inc. (NYSE: STZ) leads today’s list of companies reporting earnings. The spirits giant reported earnings per share of $2.87 on top of $2.30 billion in revenue. Those figures topped consensus expectations of $2.58 on top of $2.25 billion. The company also announced it had increased its 2019 fiscal guidance. Amazon.com Inc. (NASDAQ: AMZN) is generating some negative press this morning. The e-commerce giant had announced an hourly wage hike for its workers on Tuesday. However, as we dig deeper into the announcement, it turns out that the firm has eliminated monthly bonuses and stock awards from its hourly employees. In addition, Bloomberg is reporting that Chinese equipment manufacturer Super Micro may have allowed microchips that could be used for spying into equipment run in Amazon Web Services. Amazon has denied the report. In deal news, Barnes & Noble Inc. (NYSE: BKS) shares popped 18% on news that the firm is exploring a potential sale. According to reports, the firm has received interest from several parties, including the firm’s chair, Leonard Riggio, who developed Barnes & Noble’s modern franchise in 1971. Shares of BKS stock had been off about 18% since January as the firm continues to struggle against Amazon and faces a difficult retail environment. Look for other earnings reports from Costco Wholesale Corp. (NASDAQ: COST), International Speedway Corp. (NASDAQ: ISCA), and Sky Solar Holdings Ltd. (NASDAQ: SKYS)

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Motley Fool Transcription]

    International Speedway Corporation (NASDAQ:ISCA)Q3 2018 Earnings Conference CallOct. 4, 2018, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Blue Chip Stocks For 2019

Malaysia’s stock benchmark slid for a fourth day, erasing its advance for 2018, after the government said national debt was higher than previously disclosed due to some masking of accounts by the previous administration.

The FTSE Bursa Malaysia KLCI Index fell 1.4 percent to 1,778.41, the lowest since Dec. 27, as of 10:33 a.m. in Kuala Lumpur. It had slumped as much as 2 percent. The benchmark lost gains of as much as 5.5 percent this year, as bank shares led Thursday’s decline.

"People are selling first and asking questions later," said Clive McDonnell, the Singapore-based head of emerging market equity strategy at Standard Chartered Bank. "I don’t think that’s a surprise to see those outflows given the uncertainty until there’s greater clarity on economic management going forward."

#lazy-img-328011050:before{padding-top:56.25%;}

There was sudden panic selling, said Ang Kok Heng, chief investment officer at Phillip Capital Management Sdn. in Kuala Lumpur. Still, "we are accumulating selected blue chips as these have been battered. The outlook of the economy would be better with good corporate governance and a government that is more efficient and fair."

Top 5 Blue Chip Stocks For 2019: Daiichi Sankyo Company, Limited (DSKYF)

Advisors’ Opinion:

  • [By ]

    Daiichi Sankyo (OTCPK:DSKYF)

    There are 4 members of the EGF receptor family, but in cancer research we tend to focus mainly on the first two: EGFR and HER2. But we are also gaining a better understanding of the third family member, HER3, which is an odd duck because of its willingness to form dimers not with itself, but with other members of the EGFR family. And it is highly active in PI3K/Akt signaling, as well. So it’s no surprise that companies are trying to exploit this receptor as a therapeutic target. DSKYF’s U3-1402 is an antibody-drug conjugate targeting HER3 and delivering a lethal payload to tumor cells. This phase 1/2 study focused on the use of this agent in metastatic breast cancer overexpressing HER3.

Top 5 Blue Chip Stocks For 2019: MDC Partners Inc.(MDCA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news stories that may have effected Accern’s analysis:

    Get MDC Partners alerts:

    $0.09 Earnings Per Share Expected for MDC Partners Inc (MDCA) This Quarter (americanbankingnews.com) Head-To-Head Review: MDC Partners (MDCA) vs. HAVAS (HAVSF) (americanbankingnews.com) Telaria (TLRA) & MDC Partners (MDCA) Head to Head Survey (americanbankingnews.com) Comparing WPP (WPP) & MDC Partners (MDCA) (americanbankingnews.com)

    Shares of MDC Partners traded up $0.15, reaching $4.80, during midday trading on Monday, according to Marketbeat.com. 391,100 shares of the company were exchanged, compared to its average volume of 478,690. The stock has a market cap of $278.13 million, a PE ratio of 7.87, a P/E/G ratio of 1.99 and a beta of 1.13. MDC Partners has a 1-year low of $3.80 and a 1-year high of $12.26. The company has a debt-to-equity ratio of -3.37, a current ratio of 0.74 and a quick ratio of 0.74.

  • [By Lisa Levin]

    Shares of MDC Partners Inc. (NASDAQ: MDCA) were down 33 percent to $ 4.575 after a first-quarter earnings miss.

    Hudson Technologies Inc. (NASDAQ: HDSN) was down, falling around 32 percent to $2.7799 after the company reported downbeat Q1 earnings.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

Top 5 Blue Chip Stocks For 2019: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Shane Hupp]

    HC Wainwright set a $5.00 price objective on Antares Pharma (NASDAQ:ATRS) in a research report released on Friday. The brokerage currently has a buy rating on the specialty pharmaceutical company’s stock.

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Top 5 Blue Chip Stocks For 2019: PIMCO California Municipal Income Fund III(PZC)

Advisors’ Opinion:

  • [By Max Byerly]

    PZ Cussons (LON:PZC) had its price objective decreased by Numis Securities from GBX 255 ($3.40) to GBX 230 ($3.06) in a research note issued to investors on Thursday. Numis Securities currently has a hold rating on the stock.

  • [By Ethan Ryder]

    Headlines about Pimco CA Muni. Income Fund III (NYSE:PZC) have trended somewhat positive recently, Accern reports. The research group scores the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Pimco CA Muni. Income Fund III earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned news headlines about the investment management company an impact score of 48.0089575306336 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Top 5 Blue Chip Stocks For 2019: Prudential Financial Inc.(PRU)

Advisors’ Opinion:

  • [By Shane Hupp]

    NN Investment Partners Holdings N.V. increased its holdings in Prudential Financial Inc (NYSE:PRU) by 0.1% during the 2nd quarter, Holdings Channel reports. The firm owned 2,197,076 shares of the financial services provider’s stock after buying an additional 2,780 shares during the period. Prudential Financial accounts for approximately 1.5% of NN Investment Partners Holdings N.V.’s portfolio, making the stock its 10th largest position. NN Investment Partners Holdings N.V.’s holdings in Prudential Financial were worth $205,450,000 at the end of the most recent reporting period.

  • [By Zacks]

    Well, given the growing demand for securitized mortgage deals, Barclays plans to package and sell these Irish loans over the next two months. The group of investors that has shown interest in buying residential mortgage backed securities includes M&G Investments, the investment management division of British insurer Prudential Plc (NYSE: PRU) and Pacific Investment Management Co. ("PIMCO").

  • [By Logan Wallace]

    KBC Group NV trimmed its holdings in shares of Prudential Financial Inc (NYSE:PRU) by 11.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 260,023 shares of the financial services provider’s stock after selling 35,173 shares during the period. KBC Group NV owned about 0.06% of Prudential Financial worth $24,315,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Wesbanco Bank Inc. raised its stake in Prudential Financial Inc (NYSE:PRU) by 5.9% during the second quarter, HoldingsChannel reports. The institutional investor owned 65,335 shares of the financial services provider’s stock after acquiring an additional 3,655 shares during the period. Wesbanco Bank Inc.’s holdings in Prudential Financial were worth $6,110,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Prudential (LON:PRU) had its target price hoisted by Berenberg Bank from GBX 2,400 ($30.96) to GBX 2,600 ($33.54) in a research note published on Thursday morning, Marketbeat.com reports. They currently have a buy rating on the financial services provider’s stock.

  • [By Chuck Saletta]

    Prudential Financial (NYSE:PRU) takes such pride in its rock-solid financial condition that it uses an actual rock — the Rock of Gibraltar — as its corporate symbol. Prudential Financial backs up that claim with a balance sheet that has more cash, cash equivalents, and short-term investments than total debt on it. It also claims a debt-to-equity ratio around 0.6 and a current ratio around 1.0 , which are further signs of a solid financial condition.

Top 10 Heal Care Stocks For 2019

Good news for investors: Fund fees keep dropping. The expense ratios of some exchange-traded funds are now approaching zero. Whats more, some mutual fund sponsors that have traditionally charged commissions have begun making their funds available without loads.

See Also: New App Lets You Buy, Sell Stocks With No Fees

BlackRock, sponsor of the iShares exchange-traded funds, cut the expense ratios for 15 of its broad-market ETFs and five of its index mutual funds in October. Schwab retaliated soon thereafter, trimming fees for five of its ETFs. Last summer, Fidelity cut fees for 27 of its funds and ETFs. It now charges less for some of its index funds than does Vanguard, the indexing leader (see Fidelity Challenges Vanguard on Mutual Fund Fees). BlackRocks latest move makes iShares Core S&P 500 (IVV), which charges 0.04% annually, the lowest-cost ETF that tracks Standard & Poors 500-stock index. (The fund is a member of the Kiplinger ETF 20.)

Top 10 Heal Care Stocks For 2019: Yum! Brands, Inc.(YUM)

Advisors’ Opinion:

  • [By ]

    Among McDonald’s main rivals, identified by FactSet, are Starbucks Corp. (SBUX) , down almost 5.5%; Yum! Brands (YUM) , which owns KFC, Pizza Hut and Taco Bell, up 32%; and burger chain Sonic Corp. (SONC) , down about 2%. These are all year-over-year percentages.

  • [By Matthew Cochrane]

    There are several different avenues available to investors looking to take advantage of the surging popularity of food delivery, including restaurants, grocers, meal kits, tech companies that support payment systems, apps and other logistics, and larger corporations that will undoubtedly make waves in the space. Let’s examine some of the options.

    Company Name Type of Business Market Cap (billions) P/E Ratio (GAAP)
    Amazon.com (NASDAQ:AMZN) E-commerce/Grocery $833.5 271.78
    Blue Apron (NYSE:APRN) Meal kit delivery $0.6 N/A
    Domino’s Pizza (NYSE:DPZ) Restaurant $11.6 41.16
    GrubHub (NYSE:GRUB) Restaurant delivery $10.5 136.47
    Kroger(NYSE: KO) Grocery $20.8 24.53
    McDonald’s (NYSE:MCD) Restaurant $131.3 22.14
    Sprouts Farmers Market (NASDAQ:SFM) Grocery $2.8 18.2
    Square(NYSE:SQ) Payments $25.9 N/A
    Walmart Inc.(NYSE:WMT) Retail/Grocery $247.4 28.66
    Yum! Brands (NYSE:YUM) Restaurant $27.2 15.0

    Data source: Google Finance

  • [By Joseph Griffin]

    Stifel Financial Corp lessened its holdings in Yum! Brands, Inc. (NYSE:YUM) by 9.5% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 595,695 shares of the restaurant operator’s stock after selling 62,381 shares during the quarter. Stifel Financial Corp’s holdings in Yum! Brands were worth $50,723,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By ]

    However, Cramer did have some positive advice about dealing with China. “The one thing I tell people is that if you want surefire China trades: you go long Yum Brands (YUM) and short Yum China (YUMC) , as they have similar growth rates and similar price to earnings multiples, but only one can be brought low by the [People’s Republic of China].”

Top 10 Heal Care Stocks For 2019: WildHorse Resource Development Corporation (WRD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on WildHorse Resource Development (WRD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks For 2019: LivePerson Inc.(LPSN)

Advisors’ Opinion:

  • [By Logan Wallace]

    LivePerson, Inc. (NASDAQ:LPSN) SVP Daryl Carlough sold 425 shares of the company’s stock in a transaction dated Wednesday, June 20th. The shares were sold at an average price of $23.80, for a total value of $10,115.00. Following the completion of the sale, the senior vice president now directly owns 14,647 shares of the company’s stock, valued at $348,598.60. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

  • [By Rick Munarriz]

    Shares of LivePerson (NASDAQ:LPSN) hit all-time highs on Thursday after posting fresh financial results following Wednesday’s market close. The record day didn’t start out that way. The provider of high-tech customer support initially opened lower following its second-quarter report, as bears fretting about LivePerson’s reduced bottom-line guidance for the whole year seemed to have the upper hand over the bulls cheering on a boost to its top-line outlook. The pessimism didn’t last long.

  • [By Rick Munarriz]

    Double-digit growth is back at LivePerson (NASDAQ:LPSN). The provider of high-tech customer support reported fresh financials after Thursday’s market close, delivering its best period of year-over-year revenue growth in nearly three years.

Top 10 Heal Care Stocks For 2019: Sohu.com Inc.(SOHU)

Advisors’ Opinion:

  • [By Rick Munarriz]

    It’s now been seven months since Sohu.com (NASDAQ:SOHU) completed its objective of spinning off Sogou. Sogou had been the fastest growing component at Sohu for years. It should have taken off after trading on its own merits, but that failed to happen. Though the shares inched slightly higher in their first few days of trading, Sogou has spent most of its time since late November as a broken IPO until it finally cracked the $13 ceiling today in intraday trading.

  • [By Rick Munarriz]

    I’ve been coveringSohu.com (NASDAQ:SOHU)for awhile, so when the Chinese internet pioneer announced plans tospin off Sogou, I was more than a little interested. Sogou has been the main growth driver at Sohu for years. With Sohu’s online advertising business meandering and its internet gaming business proving volatile, search has been its crown jewel.

  • [By Joseph Griffin]

    Russell Investments Group Ltd. decreased its holdings in shares of Sohu com Ltd (NASDAQ:SOHU) by 23.4% in the first quarter, HoldingsChannel.com reports. The fund owned 108,393 shares of the information services provider’s stock after selling 33,178 shares during the quarter. Russell Investments Group Ltd.’s holdings in Sohu com were worth $3,351,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Daniel Sparks]

    Shares of Chinese internet company Sohu.com (NASDAQ:SOHU) fell as much as 11.8% on Wednesday, following the company’s first-quarter earnings release. The stock is down 8.4% at the time of this writing.

  • [By Rick Munarriz]

    The market isn’t warming up toSohu.com’s(NASDAQ:SOHU)latest financial report. Its shares are hitting their lowest levels since the summer of 2007 after the Chinese online advertising, search, and gaming specialist posted disappointing first-quarter results on Wednesday morning.

Top 10 Heal Care Stocks For 2019: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

  • [By Joseph Griffin]

    News articles about Antares Pharma (NASDAQ:ATRS) have trended somewhat positive on Sunday, according to Accern Sentiment. The research group scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Antares Pharma earned a news impact score of 0.18 on Accern’s scale. Accern also assigned news coverage about the specialty pharmaceutical company an impact score of 45.2112654396991 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Antares Pharma (ATRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks For 2019: Vishay Intertechnology, Inc.(VSH)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Vishay Intertechnology (NYSE:VSH) has earned an average rating of “Hold” from the seven ratings firms that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $21.75.

  • [By Max Byerly]

    Mercury Systems (NASDAQ: MRCY) and Vishay Intertechnology (NYSE:VSH) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership.

  • [By Max Byerly]

    Foundry Partners LLC increased its stake in shares of Vishay Intertechnology (NYSE:VSH) by 1.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 971,613 shares of the semiconductor company’s stock after purchasing an additional 13,672 shares during the period. Vishay Intertechnology accounts for about 0.8% of Foundry Partners LLC’s holdings, making the stock its 18th biggest position. Foundry Partners LLC’s holdings in Vishay Intertechnology were worth $18,072,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Heal Care Stocks For 2019: First Internet Bancorp(INBK)

Advisors’ Opinion:

  • [By Logan Wallace]

    First Internet Bancorp (NASDAQ:INBK) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Wednesday.

  • [By Max Byerly]

    Penn Capital Management Co. Inc. lowered its stake in First Internet Bancorp (NASDAQ:INBK) by 22.2% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 87,312 shares of the bank’s stock after selling 24,888 shares during the period. Penn Capital Management Co. Inc.’s holdings in First Internet Bancorp were worth $3,231,000 as of its most recent SEC filing.

  • [By Rich Smith]

    The year was 1999 and “internet” stocks were all the rage. On opposite sides of the country, two banks — BofI Holding (NASDAQ:BOFI) and First Internet Bancorp (NASDAQ:INBK)– were both betting on a business model of asset-light internet banking. Nearly two decades later, one of these banks has grown into a $2.6 billion force to be contended with, while the other lags behind with a market cap of less than $350 million.

  • [By Stephan Byrd]

    Craig Hallum began coverage on shares of First Internet Bancorp (NASDAQ:INBK). They issued a buy rating and a $50.00 target price on the stock.

    Intuit (NASDAQ:INTU) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $213.00 price target on the stock. According to Zacks, “We are optimistic on Intuit’s growing SMB exposure and believe that its strategic acquisitions will fortify this segment. Due to the continuously emerging new technologies and current market trends, cloud-based business and financial software solutions have been gaining momentum. As Intuit is already a market leader in this segment, the increased adoption helped it gain new customers, in turn, boosting the overall performance. Estimates have been stable for Intuit of late. Moreover, the company’s strategy of shifting its business to cloud-based subscription model will help generate more stable revenues over the long run. Intuit’s shares have outperformed the industry in a year’s time.”

Top 10 Heal Care Stocks For 2019: Globe Specialty Metals Inc.(GSM)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Advance Auto Parts, Inc. (NYSE: AAP) is projected to report quarterly earnings at $1.97 per share on revenue of $2.91 billion.
    Kohl's Corporation (NYSE: KSS) is expected to report quarterly earnings at $0.5 per share on revenue of $3.95 billion.
    The TJX Companies, Inc. (NYSE: TJX) is projected to report quarterly earnings at $1.02 per share on revenue of $8.47 billion.
    AutoZone, Inc. (NYSE: AZO) is estimated to report quarterly earnings at $13.01 per share on revenue of $2.72 billion.
    Dycom Industries, Inc. (NYSE: DY) is projected to report quarterly earnings at $0.7 per share on revenue of $734.86 million.
    Eaton Vance Corp. (NYSE: EV) is estimated to report quarterly earnings at $0.79 per share on revenue of $425.42 million.
    Photronics, Inc. (NASDAQ: PLAB) is expected to report quarterly earnings at $0.07 per share on revenue of $124.17 million.
    Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is estimated to report quarterly earnings at $1.93 per share on revenue of $715.15 million.
    Radcom Ltd. (NASDAQ: RDCM) is expected to post quarterly earnings at $1.96 per share on revenue of $718.59 million.
    Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) is projected to report quarterly earnings at $0.04 per share on revenue of $718.96 million.
    CYREN Ltd. (NASDAQ: CYRN) is estimated to report quarterly loss at $0.08 per share on revenue of $7.72 million.
    Ferroglobe PLC (NYSE: GSM) is projected to report quarterly earnings at $0.16 per share on revenue of $559.15 million.
    Dr. Reddy's Laboratories Limited (NYSE: RDY) is estimated to report earnings for its fourth quarter.
    BioLineRx Ltd. (NASDAQ: BLRX) is expected to report quarterly loss at $0.07 per share.
    Toll Brothers, Inc. (NYSE: TOL) is estimated to post quarterly earnings at $0.76 per share on revenue of $1.58 billion.

     

  • [By Ethan Ryder]

    TRADEMARK VIOLATION WARNING: “$559.12 Million in Sales Expected for Ferroglobe (GSM) This Quarter” was originally published by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another site, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The original version of this news story can be viewed at www.tickerreport.com/banking-finance/3385662/559-12-million-in-sales-expected-for-ferroglobe-gsm-this-quarter.html.

  • [By Lisa Levin]

    Shares of Ferroglobe PLC (NYSE: GSM) got a boost, shooting up 7 percent to $12.17 following stronger-than-expected quarterly earnings.

    Precipio, Inc. (NASDAQ: PRPO) shares were also up, gaining 42 percent to $0.597 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth.

  • [By Shane Hupp]

    TheStreet cut shares of Ferroglobe (NASDAQ:GSM) from a c- rating to a d+ rating in a research report sent to investors on Friday.

    GSM has been the subject of a number of other reports. JPMorgan Chase & Co. increased their price objective on shares of Ferroglobe from $13.50 to $15.00 and gave the company an overweight rating in a report on Wednesday, May 23rd. Zacks Investment Research raised shares of Ferroglobe from a sell rating to a hold rating in a report on Tuesday, May 29th. BidaskClub lowered shares of Ferroglobe from a sell rating to a strong sell rating in a report on Tuesday, June 5th. B. Riley cut their price objective on shares of Ferroglobe from $20.00 to $18.00 and set a buy rating for the company in a report on Wednesday, May 23rd. Finally, Oppenheimer set a $20.00 price objective on shares of Ferroglobe and gave the company a buy rating in a report on Thursday, March 29th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average price target of $18.50.

Top 10 Heal Care Stocks For 2019: Rave Restaurant Group, Inc.(RAVE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media coverage about Pizza Inn (NASDAQ:RAVE) has trended somewhat positive recently, according to Accern. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Pizza Inn earned a coverage optimism score of 0.06 on Accern’s scale. Accern also assigned news coverage about the restaurant operator an impact score of 44.1311226041984 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Top 10 Heal Care Stocks For 2019: Meredith Corporation(MDP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Goelzer Investment Management Inc. boosted its position in shares of Meredith Co. (NYSE:MDP) by 351.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 160,664 shares of the company’s stock after acquiring an additional 125,099 shares during the quarter. Meredith accounts for approximately 1.0% of Goelzer Investment Management Inc.’s investment portfolio, making the stock its 19th biggest holding. Goelzer Investment Management Inc.’s holdings in Meredith were worth $8,644,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Gabelli Funds LLC increased its holdings in shares of Meredith Co. (NYSE:MDP) by 1.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 211,200 shares of the company’s stock after buying an additional 2,000 shares during the quarter. Gabelli Funds LLC owned 0.47% of Meredith worth $11,363,000 at the end of the most recent reporting period.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million.
    AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million.
    Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion.
    Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion.
    Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion.
    Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion.
    Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million.
    Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million.
    ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million.
    Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion.
    Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion.
    Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion.
    NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million.
    World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million.
    MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million.
    Choice Hotels International, Inc. (NYSE: CH

Top Medical Stocks To Buy For 2019

If you encounter a cloud of pot smoke backstage at a KISS show, it isn't coming from the bassist's dressing room.

Gene Simmons has abstained from drugs and alcohol in his more than four decades in KISS, unlike some of his bandmates. So it came as a surprise to many when cannabis cultivation and retail company Invictus MD Strategies Corp (OTC: IVITF) — which trades under the ticker "GENE" on the TSX Venture Exchange — announced that Simmons joined the company as its "chief evangelist officer."

The 68-year-old fire-breathing rocker spoke with Benzinga about the evolution of his views on marijuana. Hear his words and take heed.

 

Simmons Motivated By Money, Medicinal Value

For Simmons, it's a financial play: he didn't want to miss out on a rapidly expanding market, and he said he's come to understand that legislation is lagging the public opinion and medical possibilities of cannabis.

“I want lawmakers to really get educated on cannabis-related topics. I want them to get their information from people who don’t have a political agenda, like a 6-year little girl with epilepsy being prescribed cannabis-based products, which seem to be miraculously either minimizing or completely curing various ailments."

Top Medical Stocks To Buy For 2019: CSP Inc.(CSPI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Headlines about CSP (NASDAQ:CSPI) have been trending somewhat positive this week, according to Accern. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CSP earned a news sentiment score of 0.07 on Accern’s scale. Accern also gave headlines about the information technology services provider an impact score of 44.9831568716707 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top Medical Stocks To Buy For 2019: PartnerRe Ltd.(PRE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Presearch (CURRENCY:PRE) traded down 2.1% against the U.S. dollar during the 1 day period ending at 11:00 AM Eastern on July 21st. Presearch has a total market capitalization of $18.94 million and $65,603.00 worth of Presearch was traded on exchanges in the last 24 hours. Over the last week, Presearch has traded 14.6% higher against the U.S. dollar. One Presearch token can now be purchased for $0.12 or 0.00001662 BTC on cryptocurrency exchanges including CoinExchange, YoBit and HitBTC.

Top Medical Stocks To Buy For 2019: Gap, Inc. (GPS)

Advisors’ Opinion:

  • [By Max Byerly]

    Element Capital Management LLC purchased a new stake in Gap Inc (NYSE:GPS) during the first quarter, according to its most recent filing with the SEC. The fund purchased 33,989 shares of the apparel retailer’s stock, valued at approximately $1,060,000.

  • [By Leo Sun]

    Over time, several of these secondary brands have become core growth drivers for their parent companies, offsetting the weaker results of the rest of the business. Let’s look at three rising stars that fit that description — American Eagles’ (NYSE:AEO) Aerie, Abercrombie & Fitch’s (NYSE:ANF) Hollister, and Gap’s (NYSE:GPS) Athleta.

  • [By JJ Kinahan]

    It was a different story for Gap Inc. (NYSE: GPS). The company’s stock fell more than 14.5 percent after it reported same-store sales climbed a little less than analysts had expected and earnings per share came in below expectations. Old Navy has been a driver for GPS, but same-store sales there rose 3 percent, down from 8 percent a year earlier.

  • [By Chris Lange]

    Gap Inc. (NYSE: GPS) was maintained as Hold at Deutsche Bank and assigned a $33 price target (versus a $32.95 close).

    Hormel Foods Corp. (NYSE: HRL) was maintained as Neutral at Buckingham Research and assigned a price target of $32 (versus a $35.42 close).

Top Medical Stocks To Buy For 2019: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

  • [By Joseph Griffin]

    News articles about Antares Pharma (NASDAQ:ATRS) have trended somewhat positive on Sunday, according to Accern Sentiment. The research group scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Antares Pharma earned a news impact score of 0.18 on Accern’s scale. Accern also assigned news coverage about the specialty pharmaceutical company an impact score of 45.2112654396991 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Antares Pharma (ATRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Insurance Stocks To Invest In 2019

These 4 Emojis Are a No-No on Wall Street

Life Expectancy Holds Steady, but Not for 95-Year-Olds

5 Uses for Life Insurance That Most People Haven’t Thought Of

Americans set the Internet ablaze speaking out on Twitter. Yet speaking live to a crowd in public is still their No. 1 fear.

To get the word from an expert on how to prepare, present and benefit from making a speech, ThinkAdvisor interviewed Bernie Swain, co-founder and chair of Washington Speakers Bureau.

Any room for adlibbing within a prepared speech?

No, especially if you tend to ramble. You’ve got to stay on-theme. If you get into side stories, you lose the audience because you’ve taken them in a different direction.

But can’t practicing too much take freshness away from one’s presentation?

Great speakers practice like a musician practices their instrument. It’s mandatory to practice but in such a way that you’re able to criticize it and get others to do the same. Practice in front of family members and your staff.  Allow them to critique your performance. I used to practice in front of my wife [WSB co-founder Paula Swain]. She’d be hard on me: “Do it again – I’m not pleased with what you’re doing.” So you need to have someone that’s honest with you and will push you to keep practicing. Then you gain confidence, and it becomes easier.

Best Insurance Stocks To Invest In 2019: CVENT, INC.(CVT)

Advisors’ Opinion:

  • [By Logan Wallace]

    CyberVein (CURRENCY:CVT) traded 7.6% lower against the US dollar during the one day period ending at 21:00 PM E.T. on June 9th. One CyberVein token can now be purchased for about $0.0625 or 0.00000853 BTC on major exchanges including Bit-Z, HitBTC and IDEX. CyberVein has a total market cap of $56.75 million and $10.82 million worth of CyberVein was traded on exchanges in the last 24 hours. During the last seven days, CyberVein has traded up 5.3% against the US dollar.

Best Insurance Stocks To Invest In 2019: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Antares Pharma (ATRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Best Insurance Stocks To Invest In 2019: CASI Pharmaceuticals, Inc.(CASI)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub downgraded shares of CASI Pharmaceuticals (NASDAQ:CASI) from a strong-buy rating to a buy rating in a report released on Saturday morning.

  • [By Maxx Chatsko]

    Shares of CASI Pharmaceuticals (NASDAQ:CASI) jumped nearly 32% today after the small-cap pharma announced a new contract drug-manufacturing pact in China. The company now will rely on Yiling Wanzhou International Pharmaceuticals for manufacturing two drugs: entecavir and cilostazol.

Top Value Stocks To Own Right Now

Wherever you look to find out about bitcoin and other cryptocurrencies, you will find one of two major lines of thought. Either cryptocurrency is a bubble that is set to burst, or it is a perfect investment solution that will make you millions. The cryptocurrency landscape is actually, in reality, more likely to rest somewhere in the middle of these two extreme outcomes. Here we consider why the cryptocurrency market is not about to burst and why it is more likely to offer ongoing success, like the dot com boom did. 
 
The bitcoin boom
There is no doubt that cryptocurrency got out of hand at the end of 2017. When bitcoin crossed the threshold to become 1,000 percent more valuable in less than a year it was clear that the brakes needed to be applied, but the increase continued from there. For those who timed it perfectly, buying at $10,000 and cashing out at $19,000, cryptocurrency has already paid out. For many others, however, the drop from $19,000 to around $9,000 at present is one that will fill them with anxiety. With bitcoin doubling in value on a daily basis a crash or correction was inevitable, but the important take away is that bitcoin did not collapse completely. Instead, the cryptocurrency corrected itself in the same way that other currencies do, and it is still a valuable investment to hold. 

Top Value Stocks To Own Right Now: Provident Financial Services, Inc(PFS)

Advisors’ Opinion:

  • [By Max Byerly]

    Provident Financial Services (NYSE: PFS) and BCB Bancorp (NASDAQ:BCBP) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

  • [By Logan Wallace]

    Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

    Get Provident Financial Services alerts:

    Head-To-Head Review: Provident Financial (PROV) versus Provident Financial Services (PFS) (americanbankingnews.com) Head-To-Head Contrast: Territorial Bancorp (TBNK) & Provident Financial Services (PFS) (americanbankingnews.com) Q3 2018 EPS Estimates for Provident Financial Services, Inc. Decreased by Piper Jaffray (PFS) (americanbankingnews.com) Provident Financial Services, Inc. (PFS) Given Average Rating of “Hold” by Brokerages (americanbankingnews.com)

    A number of research analysts have issued reports on PFS shares. Sandler O’Neill raised shares of Provident Financial Services from a “hold” rating to a “buy” rating and set a $29.00 price objective on the stock in a research report on Friday, January 26th. ValuEngine raised shares of Provident Financial Services from a “hold” rating to a “buy” rating in a research report on Wednesday, March 7th. Zacks Investment Research downgraded shares of Provident Financial Services from a “buy” rating to a “hold” rating in a research report on Wednesday, February 21st. Boenning Scattergood reissued a “hold” rating on shares of Provident Financial Services in a research report on Monday, January 29th. Finally, Piper Jaffray reissued a “hold” rating and set a $28.00 price objective on shares of Provident Financial Services in a research report on Tuesday, January 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. Provident Financial Services currently has a consensus rating of “Hold” and an average price target of $28.42.

  • [By Shane Hupp]

    Provident Financial Services (NYSE: PFS) and Dime Community Bancshares (NASDAQ:DCOM) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

  • [By Joseph Griffin]

    Clifton Bancorp (NASDAQ: CSBK) and Provident Financial Services (NYSE:PFS) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Provident Financial Services (PFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Value Stocks To Own Right Now: Lincoln National Corporation(LNC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Gideon Capital Advisors Inc. lifted its stake in shares of Lincoln National Co. (NYSE:LNC) by 36.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,080 shares of the financial services provider’s stock after acquiring an additional 2,686 shares during the quarter. Gideon Capital Advisors Inc.’s holdings in Lincoln National were worth $736,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Shane Hupp]

    Element Capital Management LLC purchased a new position in shares of Lincoln National Co. (NYSE:LNC) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 24,346 shares of the financial services provider’s stock, valued at approximately $1,779,000.

  • [By Max Byerly]

    Traders purchased shares of Lincoln National Co. (NYSE:LNC) on weakness during trading on Thursday. $47.59 million flowed into the stock on the tick-up and $34.03 million flowed out of the stock on the tick-down, for a money net flow of $13.56 million into the stock. Of all companies tracked, Lincoln National had the 32nd highest net in-flow for the day. Lincoln National traded down ($0.84) for the day and closed at $68.05

Top Value Stocks To Own Right Now: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Antares Pharma (ATRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

Top 5 Low Price Stocks To Own For 2018

Main thesis

I believe that Tuesday Morning (NASDAQ: TUES) is a potential turnaround situation with high upside and limited downside.

Business

According to their 10k,

We are a true closeout retailer, selling high-quality products at prices below those found in boutique, specialty and department stores. Our customers come to us for an ever-changing, exceptional assortment of brand names at great prices. Basically, they purchase items at a very low price from different sources and they sell it below retail.

What makes it interesting

Niche that is likely to be undisturbed by the ecommerce disruption right now Little debt ($30 million from accessing credit facility) with continued access to capital markets Increasing revenue despite industry headwinds, which means that the problem is likely to be internal. Insider buy in Concrete turnaround plan that could work (some of them are already working)

What I think the rest of the market missed

Only 1 analyst covering (according to yahoo finance) Niche presence in a market filled with big names Overall decrease in interest in the traditional brick and mortar retail sector Boring niche with little or no growth

Notable statistics

Top 5 Low Price Stocks To Own For 2018: Sonic Automotive Inc.(SAH)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Armour Residential REIT Inc. (NYSE: ARR), Ducommun Inc. (NYSE: DCO), PJT Partners Inc. (NYSE; PJT), Sonic Automotive Inc. (NYSE: SAH)and Tandy Leather Factory Inc. (NASDAQ: TLF).

Top 5 Low Price Stocks To Own For 2018: Bayer Aktiengesellschaft (BAYZF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    For the third quarter, the company reported cash and equivalents of $470.4 million, while net income came in at $50 million (includes a gain of $78.7 million from the Immunomedics’ warrant). Without the one-time gain, its loss of $28.7 million would still be an improvement over net loss of $31.8 million for the same quarter last year. For the fourth quarter, the company is guiding for ADCETRIS sales in the range of $82 million to $84 million (total revenue of $128 million to $130 million). In addition to the growing opportunity for ADCETRIS (peak sales in excess of $1 billion) and the intriguing prospects of tucatinib, the company has a promising pipeline of ADC candidates and immuno-oncology assets. Partnered programs with the likes of AbbVie (NYSE:ABBV), Astellas (OTCPK:ALPMY), Genmab (OTCPK:GMXAY), Bayer (OTCPK:BAYZF), Genentech and many more also lend additional credibility to the story.

  • [By SEEKINGALPHA.COM]

    And this is pretty important ground. Hepatocellular carcinoma can be managed with local therapy (surgery, embolization, etc.), but at its most advanced stages, the options quickly start to thin out. For a decade, the only option in systemic therapy was Bayer’s (OTCPK:BAYZF) sorafenib. Recently, the effective systemic treatment armamentarium was doubled with the approval of regorafenib for second-line therapy.

  • [By SEEKINGALPHA.COM]

    Other R&D products in Regeneron’s pipeline that we are interested in

    Fasinumab: Antibody against nerve growth factor, being developed for pain treatment like osteoarthritis. It is partnered with Teva Pharmaceutical (NASDAQ:TEVA) (for osteoarthritis, in phase 3), and is also being developed for treatment of chronic back pain. It is licensed to Mitsubishi Tanabe for the Japan territory. REGN2222: For prevention of RSV virus infection in infants, competing with Synagis from AstraZeneca (NYSE:AZN). Nesvacumab: Angiopoetin 2 antibody, being tested in combination with Eylea (in phase 2, partnered with Bayer (OTCPK:BAYZF)). Rinucumab (anti-PDGF): Being tested in treatment of wet AMD in combination with Eylea. Phase 2 trial was not successful, but the treatment duration was less (only 12 weeks versus 24 weeks for rival Ophthotech (NASDAQ:OPHT)). 28-week and 52-week data will be released later. With Ophthotech’s phase 3 failure with Fovista, we are bullish on Rinucumab’s commercial potential in wet AMD. Immuno-oncology pipeline: Checkpoint inhibitors and novel CAR-T; still in early stage.

    Click to enlarge

  • [By SEEKINGALPHA.COM]

    Online Direct Sales – Once only consumer electronics and mobile handsets, the products it offers has grown to include 15 different categories, including home appliances and a wide array of general merchandise.

    In April, JD.com became a certified member of the American Apparel & Footwear Association (AAFA), the trusted public policy and political voice of the apparel and footwear industry, a first for a Chinese e-commerce company. In the first quarter of 2017, Avene, the leading demo-cosmetic brand for sensitive skin in European pharmacies, and three brands under Georgio Armani launched flagship stores on JD.com’s direct sales platform. JD Worldwide, a cross-border e-commerce platform set up in April 2015 to provide access to international brands (including those not available in China), has retail contracts with international brands such as Wal-Mart (NYSE:WMT), Phillips, Barcelona FC, and GNC (NYSE:GNC). Recently, it’s partnered with ASDA, a leading UK retailer under the Wal-Mart umbrella, as well as Bayer (OTCPK:BAYZF) and Cetaphil. As of March 2017, it operates 263 warehouses covering a gross floor area of 5.8 million square meters. GMV from the online direct sales business was RMB107.9 billion in the first quarter of 2017, up 42% from the first quarter of 2016. Net revenues from online direct sales increased by 40% in the first quarter of 2017 as compared to the first quarter of 2016. Fulfilled orders in the first quarter of 2017 were 477.1 million, an increase of 39% from 342.1 million in the same period in 2016. Fulfilled orders placed through mobile accounted for approximately 81% of total orders fulfilled in the first quarter of 2017, an increase of 56% compared to the same period in 2016.

    Online Marketplace – Third-party sellers offer products to customers and pay a commission to JD.com. They provide transaction processing and billing services on all orders on the online marketplace and leverage their own nationwide fulfillment infrastructu

  • [By SEEKINGALPHA.COM]

    We believe that the pharmaceutical sector has received too much negative attention. Despite the risks, a few companies offer good entry opportunities. In our previous article, we recommended Akorn. Today, we have analyzed Teva. We believe that the company is in a position to thrive in the generic market, and that it is priced very attractively. Yet, we don’t like management’s aggressive M&A strategy. We don’t like very aggressive companies since large acquisitions rarely create value for the shareholders. Contributors argue that Teva has overpaid for Actavis (its latest and largest acquisition) by at least $14B. This does not surprise us since most M&A deals are too expensive. Previous corruption issues add further doubts. Unfortunately, there is no amount of profit that can convince us to invest in a company where we do not like the management. We have sold our positions in Bayer (OTCPK:BAYZF) for similar reasons. We like Bayer, but we have sold our shares because of the Bayer-Monsanto (NYSE:MON) acquisition.

Top 5 Low Price Stocks To Own For 2018: Westinghouse Air Brake Technologies Corporation(WAB)

Advisors’ Opinion:

  • [By Lee Samaha]

    On a more positive note, Flannery appears to be making ground on some key long-term objectives.

    Management feels “good” about the ability of the healthcare segment to outperform, according to Miller. Flannery claimed GE was in “active discussions” on some aviation platforms, current & lighting and distributed power, while an announcement on the divestment of transportation (rumored to be a target of Wabtec (NYSE:WAB)) is expected by the end of the second quarter. Structural cost reductions are now expected to be above the $2 billion target outlined on the investor day presentation in November 2017. Flannery outlined that he would lead the creation of a new operating system for GE based on “lean, six sigma ad agile” involving “continuous improvement and customer experience.”

    As a reminder, GE has promised $20 billion of asset sales, and the commentary on the earnings call was reassuring, particularly as the first deal (healthcare IT assets) was underwhelming.

  • [By WWW.MONEYSHOW.COM]

    Westinghouse Air Brake Technologies Corporation (WAB) scores highly based on my Warren Buffett-based model, which is based on the book Buffettology, and also the Peter Lynch-inspired approach that uses the method outlined by Lynch in One Up on Wall Street.

  • [By Joseph Griffin]

    Mountain Pacific Investment Advisers Inc. ID cut its holdings in Wabtec Co. (NYSE:WAB) by 1.2% during the first quarter, HoldingsChannel.com reports. The firm owned 226,515 shares of the transportation company’s stock after selling 2,800 shares during the period. Wabtec comprises 1.9% of Mountain Pacific Investment Advisers Inc. ID’s investment portfolio, making the stock its 25th biggest position. Mountain Pacific Investment Advisers Inc. ID’s holdings in Wabtec were worth $18,438,000 at the end of the most recent quarter.

  • [By Matthew DiLallo]

    Westinghouse Air Brake Technologies(NYSE:WAB), or Wabtec, is off to a solid start in 2018. The rail products company reported double-digit gains in revenue and earnings thanks to a combination of factors. As a result, the company remains on pace to hit its full-year guidance.

Top 5 Low Price Stocks To Own For 2018: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

Top 5 Low Price Stocks To Own For 2018: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 12% Tuesday and posted a new 52-week low of $0.29 after closing Monday at $0.33. The stock’s 52-week high is $4.46. Volume was around 5.9 million, about 8 times the daily average. The company filed Monday for Chapter 11 bankruptcy.

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 78% Monday and posted a new 52-week low of $0.31 after closing Friday at $1.40. The stock’s 52-week high is $4.46. Volume was around 7.5million, about 15 times the daily average. The company has filed for Chapter 11 bankruptcy.

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

fixed income investments

Qualcomm slid more than 4 percent Thursday after the company announced layoffs and said it would be withdrawing and refiling a merger application with Chinese authorities regarding a tie-up with Dutch semiconductor company NXP.

Sources tell CNBC that Qualcomm is “very concerned” with the fate of the deal. A Commerce Ministry spokesman said Thursday that the chipmakers would have to do more to resolve competition concerns.

“This deal will have significant influence in the industry and might have a negative impact on competition,” the unnamed spokesman for the agency told Reuters. “Qualcomm’s plan could not easily solve the problems relating to market competition.”

Refiling extends the review period and the tender offer by three months to July 25.

The U.S. chipmaker has already received approval from eight of nine required global regulators to finalize the acquisition, with Chinese clearance the only one pending.

fixed income investments: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.

fixed income investments: Endologix, Inc.(ELGX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Endologix Inc. (NASDAQ: ELGX) dropped about 9.3% on Wednesday to post a new 52-week low of $4.78 against a 52-week high of $14.50 and a Tuesday close of $5.27. Volume of about 6 million was more than 3 times the daily average of around 1.7 million. The company on Tuesday announced a temporary shipping hold on its best-selling heart device, saying there was a manufacturing issue.

  • [By Lisa Levin]

    Endologix, Inc. (NASDAQ: ELGX) shares dropped 23 percent to $7.59 as the company issued an update on Nellix PMA process. Endologix disclosed that the FDA has requested the company to provide a two-year patient follow-up data from the EVAS-FORWARD IDE study of Nellix System.

fixed income investments: V.F. Corporation(VFC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Today, the Wall Street Journal reported that Kate Spade & Co is considering a sale of the company, following pressure from activist investors given the volatile performance ever since Kate Spade became a mono brand company over 2 years ago. The article cites thatKate Spade has hired an investment bank and has reached out to possible buyers (including other retailers) althoughKate Spade has not responded. This comes at a time when brand houses like VF Corp. (VFC), PVH Corp. (PVH), Hanesbrands (HBI), Michael Kors Holdings (KORS), and Coach have said they are looking to make a branded acquisition, andKate Spade could be one of the strongest candidates. While other brands are seeing negative comps, pulling back on wholesale exposure or restructuring,Kate Spade continues to grow.

  • [By Jeremy Bowman]

    The North Face, in particular, seems like a cautionary tale. The outdoor gear and apparel maker had its IPO in 1996. By 1999 sales were falling and the company put up a $100 million loss. In 2000,VF Corporation(NYSE:VFC) acquired it for just $25.4 million, despite $238 million in sales and a once-popular brand. Today, under the guidance of VF Corp, The North Face now has more than $2 billion in annual sales.

  • [By Leo Sun]

    VF Corp. (NYSE:VFC) owns a massive portfolio of apparel companies, including The North Face, Timberland, Wrangler, Lee, and Vans. It’s raised its dividend annually for over four decades — making it an elite “dividend aristocrat” which has boosted its payout for at least 25 straight years. VF currently pays a forward yield of 3.1%, which is supported by a payout ratio of 55%. The stock trades at 21 times earnings.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Friday was V.F. Corp. (NYSE: VFC) which traded down about 11% at $74.64. The stocks 52-week range is $50.34 to $84.38. Volume was 10 million compared to the daily average volume of roughly 2.5 million.

fixed income investments: Applied Materials, Inc.(AMAT)

Advisors’ Opinion:

  • [By Sean Williams]

    A final company income seekers would be wise to give a look is Applied Materials (NASDAQ:AMAT). Applied Materials provides manufacturing equipment to semiconductor companies, meaning its business tends to be highly cyclical. If the economy is performing well, Applied Materials is probably excelling. But if semiconductor spending is down, Applied Materials is likely struggling.

  • [By Chris Neiger]

    Applied Materials (NASDAQ:AMAT) makes equipment that allows companies to manufacture semiconductors, displays, and other components for some of the most advanced technology on the planet. And just like other tech companies, Applied has to stay ahead of new trends so that it can provide the latest equipment to its customers.

  • [By Chris Neiger]

    Applied Materials (NASDAQ:AMAT) made investors very happy last year as the company’s stock price rose more than 74%. And that growth has continued into this year, with Applied Materials up more than 10% since the beginning of 2017.

  • [By Elizabeth Balboa]

    NVIDIA Corporation (NASDAQ: NVDA), Amazon.com, Inc. (NASDAQ: AMZN), Applied Materials, Inc. (NASDAQ: AMAT) and Micron Technology, Inc. (NASDAQ: MU) — “annihilated.”

  • [By William Patalon III]

    Shares of chip-equipment leader Applied Materials Inc. (Nasdaq: AMAT) have zoomed 80% since we brought them to you in May 2014.

    And they’ve jumped 8% since we re-recommended the stock back on Jan. 31.

fixed income investments: Prism Technologies Group, Inc.(PRZM)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of TOWERVIEW LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=TOWERVIEW+LLC

    These are the top 5 holdings of TOWERVIEW LLCTejon Ranch Co (TRC) – 2,795,000 shares, 28.55% of the total portfolio. Saga Communications Inc (SGA) – 1,196,723 shares, 28.51% of the total portfolio. Shares reduced by 1.22%Barnes & Noble Inc (BKS) – 2,375,000 shares, 10.25% of the total portfolio. Corning Inc (GLW) – 600,000 shares, 7.56% of the total portfolio. Barnes & Noble Education Inc

  • [By WWW.GURUFOCUS.COM]

    For the details of TOWERVIEW LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=TOWERVIEW+LLC

    These are the top 5 holdings of TOWERVIEW LLCTejon Ranch Co (TRC) – 2,795,000 shares, 28.55% of the total portfolio. Saga Communications Inc (SGA) – 1,196,723 shares, 28.51% of the total portfolio. Shares reduced by 1.22%Barnes & Noble Inc (BKS) – 2,375,000 shares, 10.25% of the total portfolio. Corning Inc (GLW) – 600,000 shares, 7.56% of the total portfolio. Barnes & Noble Education Inc

fixed income investments: Caterpillar, Inc.(CAT)

Advisors’ Opinion:

  • [By Paul Ausick]

    Caterpillar Inc. (NYSE: CAT) traded down 1.36% at $152.81. The stock’s 52-week range is $93.81 to $173.24. Volume was about half the daily average of around 6.1 million shares. The company had no specific news Friday.

  • [By Paul Ausick]

    The DJIA stock posting the largest daily percentage gain ahead of the close Thursday was Caterpillar Inc. (NYSE: CAT) which traded up 1.66% at $95.80. The stock’s 52-week range is $57.05 to $93.98. Volume was about 20% below the daily average of around 5.3 million shares. The heavy equipment maker had no specific news.

  • [By Paul Ausick]

    Of the three other stocks closest to Boeing’s yearly gain, Apple Inc. (NASDAQ: AAPL) added more than 2% to close the week up 51% for the year to date; Caterpillar Inc. (NYSE: CAT) rose by about 0.8% to a gain of more than 48%; and Visa Inc. (NYSE: V) tacked on 0.9% to bring its annual gain to 43.5%.

  • [By Paul Ausick]

    Caterpillar Inc. (NYSE: CAT) traded up 1.41% at $154.29 in a 52-week range of $90.34 to $155.18. Volume of about 3 million shares was around half the daily average. The company announced Monday that it will close plants and lay off about 880 workers.

  • [By ]

    Xi’s comments on a more open China sent shares of Boeing (BA) and Caterpillar (CAT) up 3.8% and 3.5% while Apple (AAPL) , an Action Alerts PLUS holding, rose by 1.8%.

  • [By Ben Levisohn]

    It’s never good when your accounting is challenged–and Caterpillar (CAT) got around to issuing a statement regarding recent raids of its offices.

    Agence France-Presse/Getty Images

    The Fed’s, including the IRS,raided Caterpillar’s offices last week, and this week the New York Times wrote about a Dartmouth report that alleged accounting fraud. Today, the Associated Press conveys Caterpillar’s response:

    Caterpillar, a week after its headquarters and other facilities were raided by a number of federal agencies including the Internal Revenue Service, denied that it had broken any federal tax laws.

    The IRS has challenged Caterpillars taxes for years 2007 – 2012, the company said Friday. We disagree with the IRS position, have cooperated for requests for information, and believe that we are compliant with tax laws and stand by our financial reporting.

    Shares of Caterpillar have gained 0.9% to $92.23 at 3:25 p.m. today.

financial trading

Summary

Over the past years, Lionsgate (LGF.A) (LGF.B) has been seen as both an acquirer and a potential take out target. After intense constant speculation, Lionsgate seems more than ready to go through with a sale to a number of potential buyers. For buyers, the timing is likely right as the company has recently been beaten down after earnings.

In the period surrounding earnings (Jan. 26th-Feb. 9th), Lionsgate traded down ~25% (going from $35.52 to $26.81). This trade down was the result of the company reporting Q3 2018 earnings. However, this trade down ignored the fact that the earnings posted by the company were strong. The trade down was driven by the company’s guidance that CY 2019 would be an investment year rather than the growth year that it was previously expected to be.

While the fundamental business remains strong and offers growth in 2020 and beyond, the current M&A environment will likely lead the business to be purchased before then. Some of the main suitors of the business include Amazon, Comcast (if Sky bid is lost), and Sony. Average precedent transactions imply a reasonable multiple of 25x EBITDA which implies a share price of $41.00 per share, representing a ~38% upside to where shares are currently trading.

financial trading: Apple Hospitality REIT, Inc.(APLE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on Monday.

    AptarGroup, Inc. (NYSE: ATR) – $0.3200 dividend, 1.6780 percent yield. AptarGroup reported weaker-than-expected Q3 results on Thursday.
    Fidelity Southern Corporation (NASDAQ: LION) – $0.1200 dividend, 2.6359 percent yield. The company, based in Atlanta, Georgia, provides financial products and services for customers.
    Apple Hospitality REIT Inc (NYSE: APLE) – $0.1000 dividend, 6.5826 percent yield. Apple Hospitality REIT, based in Richmond, Virginia, operates as a subsidiary of Apple REIT Companies.
    Targa Resources Corp (NYSE: TRGP) – $0.9100 dividend, 7.7299 percent yield. The Houston, Texas-based company provides midstream natura

financial trading: Anavex Life Sciences Corp.(AVXL)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Anavex Life Sciences (OTCQX:AVXL) is down ~40% since Amit Ghate said it would trade substantially lower in an interview with the PRO Weekly Digest in June (see his update comment).

  • [By WWW.MONEYSHOW.COM]

    The lead drug from Anavex Life Sciences (AVXL) — called Anavex 2-73 — has just reported very promising phase 2a results in Alzheimer’s patients at the annual CTAD conference.

financial trading: EMCORE Corporation(EMKR)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap fiber-optic networking product Applied Optoelectronics (NASDAQ: AAOI), a potential peer of EMCORE Corporation (NASDAQ: EMKR), Finisar Corporation (NASDAQ: FNSR) and Oclaro Inc (NASDAQ: OCLR), is themostshorted stock on theNASDAQ with short interest of 62.65% according to Highshortnterest.com.

  • [By Lisa Levin]

    Shares of EMCORE Corporation (NASDAQ: EMKR) got a boost, shooting up 30 percent to $8.38 after the company posted upbeat Q4 results.

    Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) shares were also up, gaining 17 percent to $56.39 after the company reported stronger-than-expected results for its third quarter and boosted its full year net income guidance.

  • [By Peter Graham]

    Small cap fiber-optic networking product Applied Optoelectronics (NASDAQ: AAOI), a potential peer of EMCORE Corporation (NASDAQ: EMKR), Finisar Corporation (NASDAQ: FNSR) and Oclaro Inc (NASDAQ: OCLR), is thefifth mostshorted stock on theNASDAQ with short interest of 47.69% according to Highshortnterest.com.

financial trading: BAE Systems PLC (BAESY)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    BAE Systems (BAESY) and other defense stocks gained on Friday morning after President Donald Trump’s strike on Syria prompted investors to consider the possibility of greater Western involvement in the Syrian conflict.

  • [By SEEKINGALPHA.COM]

    Rheinmetall is currently trading at 15.7x forward earnings and 2.5x book value, a valuation that is closer to its automotive suppliers peers. Compared to its defense peers, its valuation is clearly cheap, as shown in the next table. This shows that Rheinmetall is usually benchmarked against its auto peers, even though 53% of its sales and 41% of operating income have come from its defense unit in the past year.

    P/E P/BV Rheinmetall 15.7 2.5 Continental AG 12.4 2.9 Valeo 13.1 3.6 Brembo (OTC:BRBOF) 17.0 5.2 Leoni (OTC:LNNNY) 13.2 1.9 Auto Peers Average 14.3 3.2 Airbus 24.0 6.8 Leonardo 16.8 2.0 BAE Systems (OTCPK:BAESY) 18.5 5.7 Thales (OTCPK:THLEY) 22.4 4.3 Defense Sector Average 19.2 4.4

    Source: Bloomberg

financial trading: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.

financial trading: Coffee Holding Co., Inc.(JVA)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart for Farmer Brothers Co shows an outstanding outperformance while large capStarbucks Corporation has been flat for more than a year and both iPath Bloomberg Coffee Subindex Total Return SM Index ETN and small cap Coffee Holding Co, Inc (NASDAQ: JVA) have underperformed:

Best Medical Stocks To Own Right Now

Scott Kicks Off Battle Over Senate Tax Bill Life Provisions

What Brighthouse Told Investors About Distribution

Senate Republicans to Add ACA Mandate Fight to Tax Fight

The Republican tax plans are suddenly looking a lot more like health care bills, with provisions that may affect coverage and increase medical expenses for millions of families.

The House version of the tax bill, which President Donald Trump endorsed on Tuesday, would end a deduction that allows families of disabled children and elderly people to write off large medical expenses. The Senate plan would repeal the Affordable Care Act requirement that most Americans carry insurance, a move that insurers promise would raise premiums in the nationwide individual insurance market.

The provisions would help offset the cost of large tax cuts for corporations and individuals. But the move has sparked a new wave of opposition from the health care industry and others who are concerned about its impact — the same political headwinds that tanked Republican efforts to repeal the Affordable Care Act earlier this year.

Best Medical Stocks To Own Right Now: Juniper Pharmaceuticals, Inc.(JNP)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested shorting women’s health stock Juniper Pharmaceuticals (NASDAQ: JNP):

    Juniper Pharmaceuticals shares have yet to break under a key support level at $5.00. But, waiting until that happens may be too late. After some continued testing of that floor, if-and-when the support should break, the ensuing selloff could materialize in a hurry. If you’re not it at the time it happens, you may not be able to get in at a decent price.

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap women’s health therapeutic stock Juniper Pharmaceuticals (NASDAQ: JNP):

Best Medical Stocks To Own Right Now: Wyndham Worldwide Corp(WYN)

Advisors’ Opinion:

  • [By Lee Jackson]

    The chief financial officerat Wyndham Worldwide Corp. (NYSE: WYN) wasselling stock this past week. Thomas Conforti parted with 25,900 shares of the hotel giant at $82.41 apiece. The total for the trade was posted at $2 million. The shares closed Friday at $82.65. The 52-week range is $62.60 to $86.72, and the consensus price target is $90.

  • [By Lisa Levin]

    Wednesday afternoon, the cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Conn's Inc (NASDAQ: CONN) and Wyndham Worldwide Corporation (NYSE: WYN).

  • [By Travis Hoium]

    Shares of hotel brand Wyndham Worldwide Corporation (NYSE:WYN) jumped as much as 11.1% in trading Wednesday after reporting first-quarter 2017 earnings. At 3:45 p.m. EDT on Wall Street, shares were still up an impressive 9.6% on the day.

Best Medical Stocks To Own Right Now: TrovaGene, Inc.(TROV)

Advisors’ Opinion:

  • [By Lisa Levin]

    TrovaGene Inc (NASDAQ: TROV) was down, falling around 42 percent to $0.25. Trovagene priced its 15 million share common stock offering at $0.30 per share.

  • [By Lisa Levin]

    TrovaGene Inc (NASDAQ: TROV) was down, falling around 40 percent to $0.26. Trovagene priced its 15 million share common stock offering at $0.30 per share.

  • [By Lisa Levin]

    Shares of TrovaGene Inc (NASDAQ: TROV) were down 13 percent to $5.28. Trovagene reported a Q4 loss of $(0.26) per share.

    Sunrun Inc (NASDAQ: RUN) was down, falling around 13 percent to $6.22. Sunrun reported a Q4 loss of $(0.15) per share on revenue of $99.6 million.

  • [By Paul Ausick]

    TrovaGene Inc. (NASDAQ: TROV) dropped about 44% Friday to post a new 52-week low of $0.24 after closing at $0.43 on Thursday. Volume was around 12.5 million, about 20 times the daily average of around 650,000. The firm this morning priced an offering of 15 million shares and warrants to purchase up to another 15 million shares at $0.30 per unit.

Best Medical Stocks To Own Right Now: Synchronoss Technologies Inc.(SNCR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Synchronoss Technologies, Inc. (NASDAQ: SNCR) got a boost, shooting up 34 percent to $16.35. Synchronoss Technologies confirmed the receipt of indication of interest from Siris Capital Group to acquire all outstanding shares for $18 per share in cash.

  • [By Lisa Levin]

    Synchronoss Technologies, Inc. (NASDAQ: SNCR) shares dropped 39 percent to $10.27 after Siris Capital disclosed that it is no longer interested in an all cash takeover of the company. Synchronoss Technologies said that it continues to explore full range of alternatives, including sale.

  • [By Lisa Levin]

    In trading on Wednesday, financial shares fell 1.72 percent. Meanwhile, top losers in the sector included Whitestone REIT (NYSE: WSR), down 8 percent, and Synchronoss Technologies, Inc. (NASDAQ: SNCR), down 7 percent.

  • [By Jim Robertson]

    On Tuesday, our Elite Opportunity Pronewsletter suggested going long on small cap cloud software and services stock Synchronoss Technologies (NASDAQ: SNCR):

  • [By Paul Ausick]

    Synchronoss Technologies Inc. (NASDAQ: SNCR) posted a new 52-week low of $9.95 on Tuesday, down about 41% from Monday’s closing price of $16.75. The stock’s 52-week high is $49.94. Volume totaled around 19 million shares, about 20 times the daily average. The company said this morning that takeover talks by private equity firm Siris Capital Group had ended without an agreement.

Best Medical Stocks To Own Right Now: Logitech International S.A.(LOGI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Mad Catz Interactive, Inc. (USA) (NYSE: MCZ) shares were also up, gaining 35 percent to $0.260 as the company disclosed that it has sold its Saitek simulation product line to Logitech International SA (USA) (NASDAQ: LOGI) for $13 million in cash.

  • [By WWW.THESTREET.COM]

    For his “Executive Decision” segment, Cramer once again sat down with Bracken Darrell, president and CEO of Logitech (LOGI) , the computer accessory maker with shares that are up 27% since Cramer last checked in back in November.

Best Medical Stocks To Own Right Now: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.